Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Continuous safety monitoring for randomized controlled clinical trials.

Piller LB, Silverman MH, Ball G.

Contemp Clin Trials. 2011 Sep;32 Suppl 1:S1. doi: 10.1016/j.cct.2011.03.014. Epub 2011 Mar 31. No abstract available.

PMID:
21458597
[PubMed - indexed for MEDLINE]
2.

Continuous safety monitoring for randomized controlled clinical trials with blinded treatment information. Part 1: Ethical considerations.

Ball G, Piller LB, Silverman MH.

Contemp Clin Trials. 2011 Sep;32 Suppl 1:S2-4. doi: 10.1016/j.cct.2011.05.010. Epub 2011 Jun 6.

PMID:
21664987
[PubMed - indexed for MEDLINE]
3.

Discussion of paper by Korn and Freidlin.

Wittes J.

Am J Bioeth. 2011 Mar;11(3):13-4. doi: 10.1080/15265161.2010.546480. No abstract available.

PMID:
21400376
[PubMed - indexed for MEDLINE]
4.

Interim analysis in randomized trials: DAMOCLES' sword?

Besselink MG, van der Graaf Y, Gooszen HG.

J Clin Epidemiol. 2010 Apr;63(4):353-4. doi: 10.1016/j.jclinepi.2009.07.004. Epub 2009 Dec 2. No abstract available.

PMID:
19959333
[PubMed - indexed for MEDLINE]
5.

The many moral responsibilities of independent data-monitoring committees.

Braillon A.

Am J Bioeth. 2011 Mar;11(3):16-7. doi: 10.1080/15265161.2010.546475. No abstract available.

PMID:
21400378
[PubMed - indexed for MEDLINE]
6.

Early stopping rules in oncology: considerations for clinicians.

Mukherjee SD, Goffin JR, Taylor V, Anderson KK, Pond GR.

Eur J Cancer. 2011 Nov;47(16):2381-6. doi: 10.1016/j.ejca.2011.05.019. Epub 2011 Jun 16. Review.

PMID:
21684153
[PubMed - indexed for MEDLINE]
7.

The Children's Oncology Group routinely applies "lack of efficacy" interim monitoring to its randomized clinical trials.

Anderson JR, Krailo M.

Am J Bioeth. 2011 Mar;11(3):18-9. doi: 10.1080/15265161.2011.552357. No abstract available.

PMID:
21400379
[PubMed - indexed for MEDLINE]
8.

Inefficacy interim monitoring procedures in randomized clinical trials: the need to report.

Korn EL, Freidlin B.

Am J Bioeth. 2011 Mar;11(3):2-10. doi: 10.1080/15265161.2010.546471.

PMID:
21400374
[PubMed - indexed for MEDLINE]
9.

The dilemma of data-safety monitoring: provision of significant new data to research participants.

Peppercorn J, Buss WG, Fost N, Godley PA.

Lancet. 2008 Feb 9;371(9611):527-9. doi: 10.1016/S0140-6736(08)60239-1. No abstract available.

PMID:
18262043
[PubMed - indexed for MEDLINE]
10.

The dangers of stopping a trial too early.

Briel M, Bassler D, Wang AT, Guyatt GH, Montori VM.

J Bone Joint Surg Am. 2012 Jul 18;94 Suppl 1:56-60. doi: 10.2106/JBJS.K.01412.

PMID:
22810449
[PubMed - indexed for MEDLINE]
11.

Data and safety monitoring during randomized controlled trials of nursing interventions.

Artinian NT, Froelicher ES, Vander Wal JS.

Nurs Res. 2004 Nov-Dec;53(6):414-8.

PMID:
15586138
[PubMed - indexed for MEDLINE]
12.

Continuous safety monitoring for randomized controlled clinical trials with blinded treatment information. Part 3: Design considerations.

Ball G, Silverman MH.

Contemp Clin Trials. 2011 Sep;32 Suppl 1:S8-10. doi: 10.1016/j.cct.2011.05.011. Epub 2011 Jun 6.

PMID:
21664988
[PubMed - indexed for MEDLINE]
13.

Data monitoring (and safety) committees--what are they and why do we need them? Primary Care Alliance for Clinical Trials (PACT) Network.

Pirotta M, Chondros P; Primary Care Alliance for Clinical Trials Network.

Aust Fam Physician. 2004 Nov;33(11):950-1, 956. Review. No abstract available.

PMID:
15584339
[PubMed - indexed for MEDLINE]
Free Article
14.

Stopping rules, interim analyses and data monitoring committees.

Ashby D, Machin D.

Br J Cancer. 1993 Dec;68(6):1047-50. No abstract available.

PMID:
8260354
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Clinical trial registration promotes patient protection and benefit, advances the trust of everyone, and is required.

Irwin RS.

Chest. 2007 Mar;131(3):639-41. No abstract available.

PMID:
17356071
[PubMed - indexed for MEDLINE]
16.

Design of randomized controlled trials.

Stanley K.

Circulation. 2007 Mar 6;115(9):1164-9. Review. No abstract available.

PMID:
17339574
[PubMed - indexed for MEDLINE]
Free Article
17.

Monitoring the randomized trials of the Women's Health Initiative: the experience of the Data and Safety Monitoring Board.

Wittes J, Barrett-Connor E, Braunwald E, Chesney M, Cohen HJ, Demets D, Dunn L, Dwyer J, Heaney RP, Vogel V, Walters L, Yusuf S.

Clin Trials. 2007;4(3):218-34.

PMID:
17715247
[PubMed - indexed for MEDLINE]
18.

Data monitoring and safety committees and their operations.

Rouse DJ.

Obstet Gynecol Surv. 2003 May;58(5):329-36. Review.

PMID:
12719675
[PubMed - indexed for MEDLINE]
19.

Unique roles of a data and safety monitoring board in vaccine safety trials with compressed timelines and urgent implications.

Scheifele D, Duval B, De Serres G, Skowronski DM.

Control Clin Trials. 2003 Feb;24(1):99-104.

PMID:
12559648
[PubMed - indexed for MEDLINE]
20.

The statistician and the data monitoring committee.

D'Agostino RB Sr.

Stat Med. 2004 May 30;23(10):1501-2. No abstract available.

PMID:
15122726
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk